| Year |
Title |
Altmetric |
| 2023
|
HFE hemochromatosis in African Americans: Prevalence estimates of iron overload and iron overload-related disease.
American Journal of the Medical Sciences.
365:31-36.
2023
|
|
| 2022
|
HLA-A*03, the hemochromatosis ancestral haplotype, and phenotypes of referred hemochromatosis probands with HFE p.C282Y homozygosity.
Hereditas.
159.
2022
|
|
| 2022
|
Iron overload phenotypes and HFE genotypes in white hemochromatosis and iron overload screening study participants without HFE p. C282Y/p.C282Y.
PLoS One.
17.
2022
|
|
| 2022
|
Estimates of West African Ancestry in African Americans Using Alleles of Iron-Related Genes HJV, SLC40A1, and TFR2.
Genetic Testing and Molecular Biomarkers.
26:96-102.
2022
|
|
| 2021
|
Factors associated with IgG levels in adults with IgG subclass deficiency.
BMC Immunology.
22.
2021
|
|
| 2020
|
Characterization of adult patients with IgG subclass deficiency and subnormal IgG2.
PLoS One.
15.
2020
|
|
| 2020
|
Estimates of European American Ancestry in African Americans Using HFE p.C282Y.
Genetic Testing and Molecular Biomarkers.
24:578-583.
2020
|
|
| 2020
|
HLA-A and -B Type and Haplotype Frequencies in IgG Subclass Deficiency Subgroups.
Archivum Immunologiae et Therapiae Experimentalis.
68.
2020
|
|
| 2020
|
Prevalence of iron deficiency in 62,685 women of seven race/ethnicity groups: The HEIRS Study.
PLoS One.
15.
2020
|
|
| 2018
|
Insulin resistance and metabolic syndrome: Clinical and laboratory associations in African Americans without diabetes in the hemochromatosis and iron overload screening study.
Metabolic Syndrome and Related Disorders.
16:267-273.
2018
|
|
| 2017
|
White blood cells and subtypes in HFE p.C282Y and wild-type homozygotes in the Hemochromatosis and Iron Overload Screening Study.
Blood Cells, Molecules and Diseases.
63:9-14.
2017
|
|
| 2017
|
Diabetes in HFE Hemochromatosis.
Journal of Diabetes Research.
2017.
2017
|
|
| 2017
|
Fibromyalgia in 300 adult index patients with primary immunodeficiency.
Clinical and Experimental Rheumatology.
35:68-73.
2017
|
|
| 2016
|
Undiagnosed diabetes and impaired fasting glucose in HFE C282Y homozygotes and HFE wild-type controls in the HEIRS study
2016
|
|
| 2016
|
Risk Factors for Insulin Resistance, Metabolic Syndrome, and Diabetes in 248 HFE C282Y Homozygotes Identified by Population Screening in the HEIRS Study.
Metabolic Syndrome and Related Disorders.
14:94-101.
2016
|
|
| 2016
|
Selective Subnormal IgG1 in 54 Adult Index Patients with Frequent or Severe Bacterial Respiratory Tract Infections.
Journal of Immunology Research.
2016.
2016
|
|
| 2016
|
Selective subnormal IgG3 in 121 adult index patients with frequent or severe bacterial respiratory tract infections.
Cellular Immunology.
299:50-57.
2016
|
|
| 2015
|
HFE gene: Structure, function, mutations, and associated iron abnormalities.
Gene.
574:179-192.
2015
|
|
| 2015
|
Serum ferritin, insulin resistance, and metabolic syndrome: Clinical and laboratory associations in 769 non-hispanic whites without diabetes mellitus in the HEIRS study.
Metabolic Syndrome and Related Disorders.
13:57-63.
2015
|
|
| 2014
|
Diabetes in first-degree family members: A predictor of type 2 diabetes in 159 nonscreening alabama hemochromatosis probands with HFE C282Y homozygosity.
Diabetes reviews (Alexandria, Va.).
37:259-266.
2014
|
|
| 2013
|
Effects of highly conserved major histocompatibility complex (MHC) extended haplotypes on iron and low CD8+ T lymphocyte phenotypes in HFE C282Y homozygous hemochromatosis patients from three geographically distant areas.
PLoS One.
8.
2013
|
|
| 2013
|
Association between celiac disease and iron deficiency in caucasians, but not non-caucasians.
Clinical Gastroenterology and Hepatology.
11:808-814.
2013
|
|
| 2012
|
Associations between single nucleotide polymorphisms in iron-related genes and iron status in multiethnic populations.
PLoS One.
7.
2012
|
|
| 2012
|
Increased Risk of Death From Iron Overload Among 422 Treated Probands With HFE Hemochromatosis and Serum Levels of Ferritin Greater Than 1000 μg/L at Diagnosis.
Clinical Gastroenterology and Hepatology.
10:412-416.
2012
|
|
| 2012
|
Dietary iron intake and serum ferritin concentration in 213 patients homozygous for the HFEC282Y hemochromatosis mutation.
Canadian Journal of Gastroenterology and Hepatology.
26:345-349.
2012
|
|
| 2011
|
Genome-wide association study identifies genetic loci associated with iron deficiency.
PLoS One.
6.
2011
|
|
| 2010
|
Longer survival associated with HLA-A 03, B 14 among 212 hemochromatosis probands with HFE C282Y homozygosity and HLA-A and -B typing and haplotyping.
European Journal of Haematology.
85:439-447.
2010
|
|
| 2010
|
Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 Hemochromatosis and Iron Overload Screening (HEIRS) Study participants.
Blood Cells, Molecules and Diseases.
44:252-256.
2010
|
|
| 2010
|
Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study.
American Journal of Hematology.
85:101-105.
2010
|
|
| 2010
|
Relationships of serum free thyroxine and erythrocyte measures in euthyroid HFE C282Y homozygotes and control subjects: The HEIRS Study.
International Journal of Laboratory Hematology.
32:282-287.
2010
|
|
| 2009
|
HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.
American Journal of Hematology.
84:710-714.
2009
|
|
| 2009
|
HAMP promoter mutation nc.-153C>T in 785 HEIRS Study participants.
The hematology journal : the official journal of the European Haematology Association / EHA.
94:1465.
2009
|
|
| 2009
|
Hemochromatosis and Vibrio vulnificus wound infections.
Journal of Clinical Gastroenterology.
43:890-893.
2009
|
|
| 2009
|
Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy.
Blood Cells, Molecules and Diseases.
43:119-128.
2009
|
|
| 2009
|
Kidney function influences warfarin responsiveness and hemorrhagic Complications.
Journal of the American Society of Nephrology.
20:912-921.
2009
|
|
| 2009
|
Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participants.
Blood Cells, Molecules and Diseases.
42:150-154.
2009
|
|
| 2009
|
HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol the Hemochromatosis and Iron Overload Screening study.
Circulation: Cardiovascular Genetics.
2:34-37.
2009
|
|
| 2009
|
A Comparison Between Whites and Blacks With Severe Multi-Organ Iron Overload Identified in 16,152 Autopsies.
Clinical Gastroenterology and Hepatology.
7.
2009
|
|
| 2009
|
HFE hemochromatosis and hepatic sarcoid.
American Journal of the Medical Sciences.
337:386-390.
2009
|
|
| 2009
|
Screening for iron overload: Lessons from the HEmochromatosis and IRon Overload Screening (HEIRS) study.
Canadian Journal of Gastroenterology and Hepatology.
23:769-772.
2009
|
|
| 2008
|
Screening for hemochromatosis and iron overload: Satisfaction with results notification and understanding of mailed results in unaffected participants of the HEIRS study.
Genetic Testing and Molecular Biomarkers.
12:491-500.
2008
|
|
| 2008
|
VKORC1 polymorphims, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans.
Pharmacogenomics.
9:1445-1458.
2008
|
|
| 2008
|
Accuracy of Family History of Hemochromatosis or Iron Overload: The Hemochromatosis and Iron Overload Screening Study.
Clinical Gastroenterology and Hepatology.
6:934-938.
2008
|
|
| 2008
|
Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and iron overload screening study.
International Journal of Laboratory Hematology.
30:300-305.
2008
|
|
| 2008
|
Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population.
American Journal of Hematology.
83:618-626.
2008
|
|
| 2008
|
Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: The HEIRS study.
Thyroid.
18:831-838.
2008
|
|
| 2008
|
Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.
Pharmacogenomics.
9:511-526.
2008
|
|
| 2008
|
Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS Study initial screening.
American Journal of Hematology.
83:126-132.
2008
|
|
| 2008
|
Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin.
Clinical Pharmacology and Therapeutics.
83:312-321.
2008
|
|
| 2008
|
Bivariate mixture modeling of transferrin saturation and serum ferritin concentration in Asians, African Americans, Hispanics, and whites in the Hemochromatosis and Iron Overload Screening (HEIRS) Study
2008
|
|
| 2008
|
Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.
Canadian Journal of Gastroenterology and Hepatology.
22:923-930.
2008
|
|
| 2007
|
Biological Variability of Transferrin Saturation and Unsaturated Iron-Binding Capacity.
American Journal of Medicine.
120.
2007
|
|
| 2007
|
DMPK-associated myotonic dystrophy and CTG repeats in Alabama African Americans
2007
|
|
| 2007
|
Results communication and patient education after screening for possible hemochromatosis and iron overload: Experience from the HEIRS Study of a large ethnically and linguistically diverse group.
Genetics in Medicine.
9:778-791.
2007
|
|
| 2007
|
Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
American Journal of Hematology.
82:898-905.
2007
|
|
| 2007
|
Genetic screening for iron overload: No evidence of discrimination at 1 year
2007
|
|
| 2007
|
HFE C282Y homozygotes aged 25-29 years at HEIRS study initial screening.
Genetic Testing and Molecular Biomarkers.
11:269-275.
2007
|
|
| 2007
|
SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent.
Blood Cells, Molecules and Diseases.
39:206-211.
2007
|
|
| 2007
|
African Americans at Risk for Increased Iron Stores or Liver Disease.
American Journal of Medicine.
120.
2007
|
|
| 2007
|
A genome-wide linkage scan for iron phenotype quantitative trait loci: The HEIRS family study
2007
|
|
| 2007
|
Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
Blood Cells, Molecules and Diseases.
38:247-252.
2007
|
|
| 2007
|
Influence of CYP2C9 genotype on warfarin dose among African-Americans and European-Americans.
Personalized Medicine.
4:157-169.
2007
|
|
| 2007
|
Serum ferritin and transferrin saturation in Asians and Pacific islanders.
JAMA Internal Medicine.
167:722-726.
2007
|
|
| 2007
|
Psychosocial impact of genetic testing for hemochromatosis in the HEIRS Study: A comparison of participants recruited in Canada and in the United States.
Genetic Testing and Molecular Biomarkers.
11:55-64.
2007
|
|
| 2006
|
Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the hemochromatosis and iron overload screening (HEIRS) study.
Diabetes reviews (Alexandria, Va.).
29:2084-2089.
2006
|
|
| 2006
|
Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study.
Genetics in Medicine.
8:681-687.
2006
|
|
| 2006
|
Geographic and racial/ethnic differences in HFE mutation frequencies in the hemochromatosis and iron overload screening (HEIRS) study
2006
|
|
| 2006
|
Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy.
Blood Cells, Molecules and Diseases.
37:100-106.
2006
|
|
| 2006
|
Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
BMC Medical Genomics.
7.
2006
|
|
| 2006
|
Predictors of belief that genetic test information about hemochromatosis should be shared with family members.
Genetic Testing and Molecular Biomarkers.
10:50-59.
2006
|
|
| 2006
|
Three kinships with ALAS2 P520L (c. 1559 C → T) mutation, two in association with severe iron overload, and one with sideroblastic anemia and severe iron overload.
Blood Cells, Molecules and Diseases.
36:292-297.
2006
|
|
| 2006
|
Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and whites in the Hemochromatosis and Iron Overload Screening Study
2006
|
|
| 2006
|
Liver Diseases in the Hemochromatosis and Iron Overload Screening Study.
Clinical Gastroenterology and Hepatology.
4.
2006
|
|
| 2006
|
Mixture models of serum iron measures in population screening for hemochromatosis and iron overload
2006
|
|
| 2005
|
Patient acceptability of genotypic testing for hemochromatosis in primary care.
Genetics in Medicine.
7:557-563.
2005
|
|
| 2005
|
Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.
Genetic Testing and Molecular Biomarkers.
9:231-241.
2005
|
|
| 2005
|
Total blood lymphocyte counts in hemochromatosis probands with HFE C282Y homozygosity: Relationship to severity of iron overload and HLA-A and -B alleles and haplotypes.
BMC Hematology.
5.
2005
|
|
| 2005
|
Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101 168 participants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study
2005
|
|
| 2005
|
Hemochromatosis and iron-overload screening in a racially diverse population.
New England Journal of Medicine.
352:1769-1778.
2005
|
|
| 2005
|
Genetic predictors of coronary heart disease risk factors in premenopausal African-American women
2005
|
|
| 2005
|
Stainable hepatic iron in 341 African American adults at coroner/medical examiner autopsy.
BMC Clinical Pathology.
5.
2005
|
|
| 2005
|
HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: Frequency disparity in men and women and lack of association with severity of iron overload.
Blood Cells, Molecules and Diseases.
34:38-47.
2005
|
|
| 2004
|
Allele frequencies of hemojuvelin gene (HJV) 1222N and G320V missense mutations in white and African American subjects from the general Alabama population.
BMC Medical Genomics.
5.
2004
|
|
| 2004
|
Countries of ancestry reported by hemochromatosis probands and control subjects in Central Alabama
2004
|
|
| 2004
|
Ancestry reported by white adults with cutaneous melanoma and control subjects in central Alabama.
BMC Cancer.
4.
2004
|
|
| 2004
|
Genetic cancer risk assessment and counseling: Recommendations of the national society of genetic counselors.
Journal of Genetic Counseling.
13:83-114.
2004
|
|
| 2004
|
HFE C282Y and H63D in adults with malignancies in a community medical oncology practice.
BMC Cancer.
4.
2004
|
|
| 2004
|
Genetics and cardiovascular disease.
2004
|
|
| 2003
|
Vibrio vulnificus infection in a hemodialysis patient receiving intravenous iron therapy.
Clinical Infectious Diseases.
37:63-67.
2003
|
|
| 2003
|
HLA-A and -B alleles and haplotypes in 240 index patients with common variable immunodeficiency and selective IgG subclass deficiency in central Alabama.
BMC Medical Genomics.
4.
2003
|
|
| 2003
|
Hemochromatosis and iron overload screening (HEIRS) Study design for an evaluation of 100,000 primary care-based adults.
American Journal of the Medical Sciences.
325:53-62.
2003
|
|
| 2003
|
Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y.
Blood Cells, Molecules and Diseases.
31:102-111.
2003
|
|
| 2003
|
Erratum to "The role of TNF and its receptors in Alzheimer's disease": [Neurobiology of Aging 22 (2001) 873-883].
Neurobiology of Aging.
24:519-520.
2003
|
|
| 2003
|
Genotypic and phenotypic heterogeneity of African Americans with primary iron overload.
Blood Cells, Molecules and Diseases.
31:310-319.
2003
|
|
| 2002
|
HLA-A and -B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central Alabama.
BMC Medical Genomics.
3.
2002
|
|
| 2002
|
Survey of physician knowledge about hemochromatosis.
Genetics in Medicine.
4:136-141.
2002
|
|
| 2002
|
Hemochromatosis detection in a health screening program at an Alabama forest products mill.
Journal of Occupational and Environmental Medicine.
44:745-751.
2002
|
|
| 2002
|
Juvenile hemochromatosis in the southeastern United States: A report of seven cases in two kinships.
Blood Cells, Molecules and Diseases.
29:104-115.
2002
|
|
| 2001
|
Hemochromatosis and iron therapy of Restless Legs Syndrome.
Sleep Medicine.
2:249-251.
2001
|
|
| 2001
|
Hemochromatosis in a lithuanian with HFE C282Y homozygosity and C282Y allele frequencies in the Baltic Sea region [1].
European Journal of Haematology.
67:263-264.
2001
|
|
| 2001
|
The role of TNF and its receptors in Alzheimer's disease.
Neurobiology of Aging.
22:873-883.
2001
|
|
| 2001
|
Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls.
American Journal of Medical Genetics Part A.
105:332-342.
2001
|
|
| 2001
|
A primer for predicting risk of disease in HFE-linked hemochromatosis.
Genetic Testing and Molecular Biomarkers.
5:311-316.
2001
|
|
| 2001
|
A rapid PCR-SSP assay for the hemochromatosis-associated Tyr250stop mutation in the TFR2 gene.
Genetic Testing and Molecular Biomarkers.
5:131-134.
2001
|
|
| 2001
|
HFE genotype frequencies in consecutive reference laboratory specimens: Comparisons among referral sources and association with initial diagnosis.
Genetic Testing and Molecular Biomarkers.
5:299-306.
2001
|
|
| 2001
|
HFE mutations in African-American women with non-insulin-dependent diabetes mellitus
2001
|
|
| 2001
|
Inheritance of two HFE mutations in African Americans: Cases with hemochromatosis phenotypes and estimates of hemochromatosis phenotype frequency.
Genetics in Medicine.
3:294-300.
2001
|
|
| 2001
|
Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes.
Diabetes reviews (Alexandria, Va.).
24:1764-1769.
2001
|
|
| 2001
|
Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload.
Blood Cells, Molecules and Diseases.
27:279-284.
2001
|
|
| 2000
|
Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: The NIMH Alzheimer disease genetics initiative.
American Journal of Medical Genetics Part A.
96:823-830.
2000
|
|
| 2000
|
Frequency of caucasian hemochromatosis-associated tyr250stop (y250x) mutation in the non-classicaf, transferred receptor gene tfr2 in african americans.
Blood.
96.
2000
|
|
| 2000
|
Hemochromatosis and primary antibody deficiency: Occurrence in the same individuals and frequency of HFE mutations in common variable immunodeficiency (CVID) and IgG subclass deficiency (IgGSD).
Blood.
96.
2000
|
|
| 2000
|
Transferrin saturation phenotype and HFE genotype screening for hemochromatosis and primary iron overload: Predictions from a model based on national, racial, and ethnic group composition in central alabama.
Genetic Testing and Molecular Biomarkers.
4:199-206.
2000
|
|
| 2000
|
Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics.
Academic Medicine.
75:850-852.
2000
|
|
| 2000
|
Population screening for hemochromatosis: Has the time finally come?.
Current Colorectal Cancer Reports.
2:18-26.
2000
|
|
| 1999
|
Associations of MHC genes with levels of caries-inducing organisms and caries severity in African-American women.
Human Immunology.
60:984-989.
1999
|
|
| 1999
|
Diagnosis of hemochromatosis in family members of probands: a comparison of phenotyping and HFE genotyping..
Genetics in Medicine.
1:89-93.
1999
|
|
| 1999
|
Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands.
Blood Cells, Molecules and Diseases.
25:147-155.
1999
|
|
| 1997
|
Molecular genetic testing for adult-onset disorders: The evolving laboratory, physician, patient interface.
Journal of Clinical Laboratory Analysis.
11:23-27.
1997
|
|
| 1997
|
Genetic and clinical description of hemochromatosis probands and heterozygotes: Evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis.
Blood Cells, Molecules and Diseases.
23:135-145.
1997
|
|
| 1996
|
Genetic association of 11 β-hydroxysteroid dehydrogenase type 2 flanking microsatellites with primary hypertension in African Americans.
Journal of Investigative Medicine.
44.
1996
|
|
| 1996
|
Genetic association of 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks.
Hypertension.
28:478-482.
1996
|
|
| 1996
|
Hemochromatosis: Association of severity of iron overload with genetic markers.
Blood Cells, Molecules and Diseases.
22:195-204.
1996
|
|
| 1996
|
Increased prevalence of mitral valve prolapse in IDDM..
Diabetes reviews (Alexandria, Va.).
19:672.
1996
|
|
| 1995
|
SSCP analysis and sequencing of the human prion protein gene (PRNP) detects two different 24 bp deletions in an atypical Alzheimer's disease family.
American Journal of Medical Genetics Part A.
60:12-18.
1995
|
|
| 1994
|
Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients.
Diabetologia.
37:420-427.
1994
|
|
| 1994
|
Genes within the major histocompatibility complex predict NIDDM in African-American women in Alabama.
Diabetes reviews (Alexandria, Va.).
17:1491-1494.
1994
|
|
| 1994
|
Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanning.
Diabetologia.
37:104-110.
1994
|
|
| 1994
|
HLA in ankylosing spondylitis: Is HLA-B27 the only MHC gene involved in disease pathogenesis?.
Seminars in Arthritis and Rheumatism.
23:295-309.
1994
|
|
| 1994
|
Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease.
American Journal of Clinical Nutrition.
59:940-948.
1994
|
|
| 1993
|
Concordance of 21-hydroxylase gene ratio, human leukocyte antigen haplotyping and adrenal testing results in a family with late-onset adrenal hyperplasia
1993
|
|
| 1993
|
Association of HLA phenotypes with hypertension in African Americans and Caucasoid Americans with type II diabetes, a population at risk for renal disease.
Transplantation Proceedings.
25:2400-2403.
1993
|
|
| 1993
|
Comparison of HLA phenotypes among African Americans from Alabama, Maryland, and North Carolina.
Transplantation Proceedings.
25:2404-2407.
1993
|
|
| 1991
|
A novel DRB1 Allele in DR2-positive American blacks.
Human Immunology.
30:41-44.
1991
|
|
| 1991
|
Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation.
Journal of Clinical Endocrinology and Metabolism.
73:1327-1331.
1991
|
|
| 1991
|
Autoantibodies in Black Women with Class A1 or Class GB Diabetes Mellitus.
American Journal of Perinatology.
8:103-105.
1991
|
|
| 1991
|
Gestational diabetes mellitus among African‐American women
1991
|
|
| 1991
|
Histocompatibility Antigen Subtypes in Black Women with Class A1 or Class GB Diabetes Mellitus.
American Journal of Perinatology.
8:106-109.
1991
|
|
| 1991
|
Restriction fragment length polymorphism analysis of HLA-DR, DQ, DP and C4 alleles in Caucasians with systemic lupus erythematosus.
Journal of Rheumatology.
18:14-18.
1991
|
|
| 1991
|
The relationship between maternal serum zinc levels during pregnancy and birthweight.
Early Human Development.
25:75-85.
1991
|
|
| 1991
|
X-linked codominant genes control all types of non-major histocompatibility complex-restricted cytotoxicity.
Human Immunology.
30:208-214.
1991
|
|
| 1990
|
A positive association between maternal serum zinc concentration and birth weight.
American Journal of Clinical Nutrition.
51:678-684.
1990
|
|
| 1990
|
Pseudogene/functional gene ratio in late-onset 21-hydroxylase-deficient adrenal hyperplasia.
American Journal of Obstetrics and Gynecology.
162:633-638.
1990
|
|
| 1990
|
Risk factors for gestational diabetes in black population.
Diabetes reviews (Alexandria, Va.).
13:1196-1201.
1990
|
|
| 1990
|
The effect of genetic risk information and health risk assessment on compliance with preventive behaviors.
American Journal of Health Education.
21:26-33.
1990
|
|
| 1989
|
The effect of risk assessment in conjunction with health promotion education on compliance with preventive behaviors..
Journal of Allied Health.
18:271-280.
1989
|
|
| 1989
|
AS and a 9.2 kb Pvu II class I HLA DNA restriction fragment..
Journal of Rheumatology.
16:141-142.
1989
|
|
| 1989
|
DNA analysis of HLA–DR and DQ genes in american blacks with systemic lupus erythematosus.
Arthritis and Rheumatism.
32:1243-1251.
1989
|
|
| 1989
|
Familial polyarteritis nodosa: a serologic and immunogenetic analysis.
Journal of Rheumatology.
16:181-185.
1989
|
|
| 1989
|
Genetic analysis of IDDM: The GAW5 multiplex family dataset.
Genetic Epidemiology.
6:15-20.
1989
|
|
| 1989
|
Molecular analysis of HLA‐D region genes in seropositive rheumatoid arthritis.
HLA.
34:299-308.
1989
|
|
| 1989
|
Restriction fragment polymorphisms of the HLA‐DR, HLA‐DQ, and insulin gene regions in IDDM: The GAW5 data.
Genetic Epidemiology.
6:21-26.
1989
|
|
| 1988
|
Molecular genetic studies of rheumatoid arthritis.
American Journal of Medicine.
85:23-25.
1988
|
|
| 1988
|
Restriction fragment length polymorphism analysis in ankylosing spondylitis.
American Journal of Medicine.
85:48-50.
1988
|
|
| 1988
|
Association of HLA-linked factor B with gestational diabetes mellitus in black women.
American Journal of Obstetrics and Gynecology.
159:805-806.
1988
|
|
| 1988
|
Re: Methotrexate in the treatment of arthritis and connective tissue disease.
Cleveland Clinic Journal of Medicine.
55:279.
1988
|
|
| 1987
|
Analysis of restriction fragment length polymorphisms in rheumatic diseases.
Rheumatic Disease Clinics of North America.
13:353-367.
1987
|
|
| 1987
|
Scleroderma: DR antigens, autoantibodies and clinical manifestations.
Clinical and Experimental Rheumatology.
5:317-321.
1987
|
|
| 1987
|
Association of restriction fragment-length polymorphisms with major histocompatibility complex class II phenotypes in white and black individuals.
Transplantation Proceedings.
19:826-832.
1987
|
|
| 1987
|
Toxicity to methotrexate in rheumatoid arthritis.
Journal of Rheumatology.
14:74-79.
1987
|
|
| 1987
|
Enhanced in vitro IgM rheumatoid factor synthesis in seropositive rheumatoid arthritis families
1987
|
|
| 1987
|
Risk factor surveys of the adult populations of the state of Alabama and Jefferson County..
The Alabama journal of medical sciences.
24:143-149.
1987
|
|
| 1987
|
Toxicity due to remission inducing drugs in RA..
Journal of Rheumatology.
14:175-176.
1987
|
|
| 1987
|
Analyses of hla linkage in white families with multiple cases of seropositive rheumatoid arthritis.
Arthritis and Rheumatism.
30:1115-1123.
1987
|
|
| 1987
|
Association of a 9.2‐kilobase pvu ii class i major histocompatibility complex restriction fragment length polymorphism with ankylosing spondylitis.
Arthritis and Rheumatism.
30:894-900.
1987
|
|
| 1987
|
DR beta Taq I restriction fragment length polymorphism (RFLP) associated with insulin dependent diabetes mellitus (IDDM)..
Disease Markers.
5:109-117.
1987
|
|
| 1987
|
Futility of predicting onset of type I diabetes mellitus..
Diabetes reviews (Alexandria, Va.).
10:788-789.
1987
|
|
| 1987
|
Lack of association between hla–dr2 and clinical response to methotrexate in patients with rheumatoid arthritis.
Arthritis and Rheumatism.
30:218-220.
1987
|
|
| 1986
|
HLA antigens and gold toxicity in American blacks with rheumatoid arthritis
1986
|
|
| 1986
|
DR2 positivity and response to methotrexate in rheumatoid arthritis.
Arthritis and Rheumatism.
29:151-151.
1986
|
|
| 1986
|
Host Factors in Juvenile Periodontitis
1986
|
|
| 1986
|
Purification and characterization of recombinant murine immune interferon.
Brain Research.
205:200-204.
1986
|
|
| 1985
|
HLA restriction fragment length polymorphisms associated with insulin-dependent diabetes mellitus and the seronegative spondyloarthropathies
1985
|
|
| 1985
|
Immunotherapy of insulin-dependent diabetes..
The Alabama journal of medical sciences.
22:311-314.
1985
|
|
| 1985
|
DR antigens in systemic sclerosis: lack of clinical correlations.
HLA.
26:156-158.
1985
|
|
| 1985
|
Familial studies in human brucellosis.
HLA.
26:77-79.
1985
|
|
| 1985
|
Genetic predisposition to acute lymphocytic leukemia in American blacks. A pediatric oncology group study.
Cancer.
55:2880-2882.
1985
|
|
| 1985
|
HLA‐Bw35 and gold toxicity in rheumatoid arthritis.
Arthritis and Rheumatism.
28:236-237.
1985
|
|
| 1984
|
The complement component C4 in black Americans with Type 1 (insulin-dependent) diabetes mellitus.
Diabetologia.
26:166-168.
1984
|
|
| 1984
|
A simple methodology for the routine production and partial purification of human lymphoblastoid interferon..
Advances in Experimental Medicine and Biology.
172:269-279.
1984
|
|
| 1984
|
Association of factor B with ischemic heart disease (IHD)..
Progress in clinical and biological research.
147:479-480.
1984
|
|
| 1984
|
Dr Antigens and Gold Toxicity in white rheumatoid arthritis patients.
Arthritis and Rheumatism.
27:601-605.
1984
|
|
| 1984
|
Modification of NK cell activity by monoclonal antibodies to target cell glycoproteins
1984
|
|
| 1984
|
Productive murine leukemia virus (MuLV) infection of EL4 T-lymphoblastoid cells: selective elevation of H-2 surface expression and possible association of Thy-1 antigen with viruses..
Advances in Experimental Medicine and Biology.
172:365-381.
1984
|
|
| 1984
|
The effects of soluble membrane glycoproteins from K562 target cells on NK activity
1984
|
|
| 1983
|
DR antigen distribution in blacks with rheumatoid arthritis.
Journal of Rheumatology.
10:579-583.
1983
|
|
| 1983
|
Age at onset of insulin-dependent diabetes mellitus associated with BfF1.
Immunogenetics.
17:437-440.
1983
|
|
| 1983
|
CREG antigens differentially influence expression of extraarticular manifestations in whites and blacks with rheumatoid arthritis.
Seminars in Arthritis and Rheumatism.
13:169-173.
1983
|
|
| 1983
|
Genetic analysis of multiply-affected families of insulin-dependent diabetes mellitus (Iddm) probands
1983
|
|
| 1983
|
PHENOTYPES OF THE FOURTH COMPLEMENT COMPONENT (C4) IN BLACK AMERICANS FROM THE SOUTHEASTERN UNITED STATES.
International Journal of Immunogenetics.
10:199-204.
1983
|
|
| 1983
|
Population genetic analyses of insulin dependent diabetes mellitus using HLA allele frequencies
1983
|
|
| 1983
|
Seronegative rheumatoid arthritis and b7‐creg: disparate results.
Arthritis and Rheumatism.
26:1412-1413.
1983
|
|
| 1982
|
Increase of hla-dr4 in melanoma patients from.
Cancer Research.
42:4276-4279.
1982
|
|
| 1982
|
Properdin factor B in black Type 1 (insulin-dependent) diabetic patients.
Diabetologia.
22:483-485.
1982
|
|
| 1982
|
Associations of properdin factor B with melanoma.
Cancer Genetics.
5:247-251.
1982
|
|
| 1982
|
Evidence for genetic admixture as a determinant in the occurrence of insulin-dependent diabetes mellitus in U.S. blacks.
Diabetes.
31:532-537.
1982
|
|
| 1982
|
HLA-A, -B, and -DR associations in type I diabetes mellitus with onset after age forty.
Diabetes.
31:122-125.
1982
|
|
| 1982
|
Properdin factor B and acute lymphocytic leukemia (ALL).
Cancer.
50:2369-2371.
1982
|
|
| 1982
|
Seronegative rheumatoid arthritis..
Arthritis and Rheumatism.
25:502-507.
1982
|
|
| 1981
|
A method for dialysis of microsamples.
Analytical Biochemistry.
118:399-400.
1981
|
|
| 1981
|
A technique for the detection of variable electrophoretic patterns of hair proteins.
Electrophoresis.
2:333-334.
1981
|
|
| 1981
|
Five‐year perspective of the large‐scale growth of mammalian cells in suspension culture.
Biotechnology and Bioengineering.
23:2717-2735.
1981
|
|
| 1981
|
HLA Associations with Insulin‐Dependent Diabetes Mellitus in a Sample of the American Black Population.
HLA.
17:286-293.
1981
|
|
| 1981
|
PROPERDIN FACTOR B POLYMORPHISM IN BLACK AMERICANS.
International Journal of Immunogenetics.
8:519-521.
1981
|
|
| 1980
|
HLA in Juvenile Diabetes.
New England Journal of Medicine.
302:405-406.
1980
|
|
| 1980
|
HLA in juvenile diabetes..
New England Journal of Medicine.
302:406.
1980
|
|
| 1980
|
Identification and characterization of protein antigens of two mycoplasma species.
Journal of Immunology.
124:997-999.
1980
|
|
| 1980
|
Isolation and partial characterization of the human homologue of Thy-1.
Journal of Experimental Medicine.
151:400-406.
1980
|
|
| 1979
|
Interaction of murine T-cell surface antigens with Mycoplasma hyorhinis..
Advances in Experimental Medicine and Biology.
121 B:65-80.
1979
|
|
| 1979
|
Propagation and Scaling-Up of Suspension Cultures.
Methods in Enzymology.
58:211-221.
1979
|
|
| 1978
|
New vistas in the etiology, genetics, pathogenesis and natural history of juvenile onset diabetes.
Journal of the Medical Association of the State of Alabama.
48:25-39.
1978
|
|
| 1978
|
Association of Thy-1 differentiation alloantigen with synaptic complexes isolated from mouse brain
1978
|
|
| 1978
|
Distribution of Thy-1 differentiation alloantigen in the rat nervous system and in a cell line derived from a rat peripheral neurinoma.
Developmental Neuroscience.
1:110-117.
1978
|
|
| 1978
|
Origin of the minor glycoproteins of murine leukemia viruses.
Journal of Virology.
28:84-94.
1978
|
|
| 1978
|
Selective association of murine T lymphoblastoid cell surface alloantigens with Mycoplasma hyorhinis
1978
|
|
| 1977
|
Isolation and characterization of murine cell surface components: I. Purification of milligram quantities of thy-1.1*.
Journal of Experimental Medicine.
146:986-1000.
1977
|
|
| 1977
|
Production and chemical characterization of cell membrane glycoproteins..
The Alabama journal of medical sciences.
14:166-175.
1977
|
|
| 1977
|
Production of Milligram Quantities of H-2K and Thy-1 Alloantigens by Large-Scale Mammalian Cell Culture.
Experimental Biology and Medicine.
155:296-300.
1977
|
|
| 1977
|
The developmental appearance of Thy-1 in mouse reaggregating brain cell cultures.
Developmental Biology.
60:331-335.
1977
|
|
| 1975
|
An evaluation of suspension culture systems for the growth of murine lymphoblastoid lines expressing TL and Thy‐1 alloantigens.
Biotechnology and Bioengineering.
17:629-657.
1975
|
|
| 1975
|
Design of a large‐scale mammalian cell, suspension culture facility.
Biotechnology and Bioengineering.
17:659-673.
1975
|
|
| 1975
|
Growth properties and alloantigenic expression of murine lymphoblastoid cell lines.
Journal of Experimental Medicine.
142:378-390.
1975
|
|
| 1975
|
Purification of plasma membranes from murine lymphoblastic cell lines expressing Thy 1 and Tl alloantigens
1975
|
|
| 1974
|
Estimation of the amount and tissue distribution of rat Thy‐1.1 antigen.
European Journal of Immunology.
4:598-602.
1974
|
|
| 1973
|
Characterization of a teleost immunoglobulin: The immune macroglobulin from the channel catfish, Ictalurus punctatus.
Comparative Biochemistry and Physiology - B: Comparative Biochemistry.
46.
1973
|
|
| 1973
|
Variations among sublines of inbred AKR mice.
Nature.
245:8-10.
1973
|
|
| 1973
|
The carbohydrate composition of invertebrate hemagglutinin subunits isolated from the lobster Panulirus argus and the oyster Crassostrea virginica.
Comparative Biochemistry and Physiology - B: Comparative Biochemistry.
44:185-189.
1973
|
|
| 1972
|
The carbohydrate composition of immunoglobulins from diverse species of vertebrates..
Journal of Immunology.
109:371-381.
1972
|
|
| 1972
|
Purification and Characterization of Two Classes of Immunoglobulins from the Marine Toad, Bufo marinus.
Biochemistry.
11:2751-2759.
1972
|
|
| 1972
|
Phylogeny of immunoglobulins-purification and physico-chemical characterization of the immune macroglobulin from the turtle, Pseudemus seripta.
Immunochemistry.
9.
1972
|
|
| 1971
|
Isolation and characterization of the immune macroglobulin from the paddlefish, Polyodon spathula..
Journal of Biological Chemistry.
246:6760-6769.
1971
|
|
| 1971
|
Species distribution of J chain..
Journal of Immunology.
107:1211-1212.
1971
|
|
| 1971
|
Isolation and physico-chemical characterization of the "IgM-like" immunologlobulin from the stingray Dasyatis americana..
Journal of Immunology.
107:782-793.
1971
|
|
| 1971
|
The carbohydrate composition of immunoglobulins G
1971
|
|
| 1971
|
Humoral antibody responses in the gar, Lepisosteus osseus..
Immunology.
20:1009-1017.
1971
|
|
| 1971
|
Phylogeny of Immunoglobulins. Characterization of a 14S Immunoglobuim from the Gar, Lepisosteus osseus.
Biochemistry.
10:2028-2036.
1971
|
|
| 1971
|
Humoral immune factors in the paddlefish, Polyodon spathula.
Comparative Biochemistry and Physiology - B: Comparative Biochemistry.
38:523-527.
1971
|
|
| 1971
|
Comparative immunology: The hemolytic complement system of the anuran amphibian, Bufo marinus
1971
|
|
| 1971
|
Bactericidal antibody response in the Pacific hagfish, Eptatretus stoutii..
Infection and Immunity.
4:160-166.
1971
|
|
| 1971
|
Tetrameric immune macroglobulins in three orders of bony fishes.
1971
|
|
| 1970
|
Biological sciences: N-Terminal sequences of immunoglobulin heavy and light chains from three species of lower vertebrates.
Nature.
228:991-992.
1970
|
|
| 1970
|
Reactions of sipunculid coelomic fluid with erythrocytes.
Life Sciences.
9:145-152.
1970
|
|
| 1969
|
Induced bactericidal response in a sipunculid worm.
Nature.
222:695.
1969
|
|
| 1969
|
Physical and chemical characterization of an oyster hemagglutinin..
Journal of Biological Chemistry.
244:4128-4135.
1969
|
|
| 1969
|
A bactericidal system in the lobster Homarus americanus.
Journal of Invertebrate Pathology.
13:463-464.
1969
|
|
| 1969
|
Attempt to induce a bactericidal response in the oyster..
Journal of Bacteriology.
97:462-463.
1969
|
|
| 1969
|
Comparative Immunology: Natural Hemolytic System of the Spiny Lobster, Panulirus argus.
Experimental Biology and Medicine.
130:322-326.
1969
|
|
| 1969
|
Immunological capabilities of the oyster Crassostrea virginica.
Comparative Biochemistry and Physiology.
29:149-160.
1969
|
|
| 1969
|
Induced Bactericidal Response in the California Spiny Lobster Panulirus interruptus.
Experimental Biology and Medicine.
132:111-114.
1969
|
|
| 1969
|
Induced bactericidal response in the hagfish..
Journal of Bacteriology.
99:626-628.
1969
|
|
| 1969
|
Lack of a bactericidal response in the earthworm Lumbricus terrestris after immunization with bacterial antigens.
Journal of Invertebrate Pathology.
14:402-406.
1969
|
|
| 1969
|
Secondary and tertiary responses of the induced bactericidin from the West Indian spiny lobster, Panulirus argus..
Journal of Bacteriology.
98:943-946.
1969
|
|
| 1969
|
Specificity of the induced bactericidin of the West Indian spiny lobster, Panulirus argus..
Journal of Bacteriology.
98:947-948.
1969
|
|
| 1968
|
T2 Bacteriophage Clearance in the Lemon Shark.
Experimental Biology and Medicine.
128:977-979.
1968
|
|
| 1968
|
An Induced Bactericidin in the Spiny Lobster, Panulirus argus.
Experimental Biology and Medicine.
128:394-398.
1968
|
|
| 1968
|
Bacteriophage clearance in the oyster (Crassotrea virginica)..
Journal of Bacteriology.
95:1260-1266.
1968
|
|
| 1967
|
Comparative immunological studies with the oyster, Crassostrea virginica
1967
|
|
| 1967
|
Complement-dependent systems and the phylogeny of immunity
1967
|
|
